bucindolol

Biotech Company Applies for FDA Permission to Market Gene-Targeted Heart Failure Drug

September 25, 2008
Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to...
Read More